Description
REVERSE DISTRIBUTION
First action · last action
2013-06-03 · 2013-06-03
Transactions
1
First transaction's obligation
$0
Base + all options value (sum of deltas)
$0
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
Parent IDV
VA797P13D0035
NAICS
561990 · ALL OTHER SUPPORT SERVICES
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-06-03+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-06-03 | +$0 | $0 | REVERSE DISTRIBUTION |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI N27NNA84NZ34)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| VA25815J0069 | 258-NETWORK CONTRACT OFFICE 18 · Q517 · MEDICAL- PHARMACOLOGY | $0 | FY2015 |
| VA25615F0014 | 256-NETWORK CONTRACT OFFICE 16 · 6505 · DRUGS AND BIOLOGICALS | $1 | FY2015 |
| VA25614F0074 | 256-NETWORK CONTRACT OFFICE 16 · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2014 |
| VA24513J1056 | 688-WASHINGTON DC · Q999 · MEDICAL- OTHER | $0 | FY2013 |
| VA25913F2571 | 259-NETWORK CONTRACT OFFICE 19 · Q517 · MEDICAL- PHARMACOLOGY | $0 | FY2013 |
| VA25813J1435 | 258-NETWORK CONTRACT OFFICE 18 · Q517 · MEDICAL- PHARMACOLOGY | $0 | FY2013 |
Other recipients under 6505 from 629-NEW ORLEANS (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25614J3853 | ABBOTT LABORATORIES INC. | 629-NEW ORLEANS | $15,438 | FY2014 |
| VA25613F1381 | SEQIRUS USA INC | 629-NEW ORLEANS | $85,020 | FY2013 |
| VA25613J1077 | UNITED THERAPEUTICS CORP | 629-NEW ORLEANS | $4,212 | FY2013 |
| VA25613F0954 | ACTELION PHARMACEUTICALS US, INC. | 629-NEW ORLEANS | $4,212 | FY2013 |
| VA25613P0721 | MCKESSON CORPORATION | 629-NEW ORLEANS | $30,968 | FY2013 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25613F1202_3600_VA797P13D0035_3600 · retrieved 2026-09-26.